Joseph Stauffer

Joseph Stauffer appears in our data through filings on Antibe Therapeutics Inc. shares, published by SEDI. Over a trading history stretching from 1 May 2020 to 6 March 2024, the count stands at 18 filings.

On the market, this insider has only ever bought: 8 purchases, €56k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 option exercises. 2024 to date brings 1 purchase and no sales.

The median purchase comes to €5,034. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

Most recently, on 6 March 2024, the filings show an open-market purchase worth €6,506 in Antibe Therapeutics Inc. Filings reach the SEDI feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.